Taiwan FDA registration 3c811c9a89818b7d4934db2940fb60d5

AtheNa Multi-Lyte GBM (Autoimmune Vasculitis) Plus Test System

TW: 宙斯自體免疫性血管炎檢驗系統
Taiwan flagTaiwan·Risk Class 2·MD·ZEUS SCIENTIFIC, INC.·Registered Mar 17, 2016 – Mar 17, 2026Expired
Registration details
Analysis ID
3c811c9a89818b7d4934db2940fb60d5
License Form
Ministry of Health Medical Device Import No. 028305
Customs Code
DHA05602830501
Company information
Manufacturer Country
United States
Authorized Representative
TRUGENE DIAGNOSTICS, INC.
Product details
Intended Use
This product targets quantitative or semi-quantitative detection of IgG antibodies to 3 different antigens (glomerular basement membrane, myeloperoxidase and protease 3) in human serum.
Product Type (Level 1)
C Immunology and microbiology devices
Product Type (Level 2)
C5660 Multiple autologous antibody immunoassay system
Import Information
Imported from abroad
Dates and status
Registration Date
Mar 17, 2016
Expiry Date
Mar 17, 2026
About this record

Access comprehensive regulatory information for AtheNa Multi-Lyte GBM (Autoimmune Vasculitis) Plus Test System in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 3c811c9a89818b7d4934db2940fb60d5 and manufactured by ZEUS SCIENTIFIC, INC.. The authorized representative in Taiwan is TRUGENE DIAGNOSTICS, INC..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices